News

JR Central rating upgraded to A1 by Moody’s, outlook shifted to stable
Moody’s Ratings has elevated the issuer and senior unsecured ratings of Central Japan Railway Company (JR Central) from A2 to A1, and altered the outlook from positive to stable. The rating upgrade is ...
Wall Street analysts initiate coverage of eToro
Investing.com -- Wall Street analysts are bullish on eToro following its recent IPO as the retail investing platform gains ...
MS downgrades McDonald’s on limited upside and structural pressures on fast food
The firm forecasts McDonald’s to grow earnings per share at about 7% annually beyond 2025, below Street estimates of 8-9%, ...
Plug Power stock gains on new Uzbekistan project
The project, backed by the Government of Uzbekistan, reinforces Plug Power’s role as a key electrolyzer provider for ...
Ondas Holdings stock soars on major defense order
Shares of Ondas Holdings Inc. (NASDAQ:ONDS) surged 11.2% following the announcement of a substantial $14.3 million purchase order from a key defense customer for multiple units of its Optimus System, ...
PolyPid shares surge on successful D-PLEX100 trial results
Investors reacted positively to the robust data, which PolyPid believes will accelerate global partnership discussions. The company also emphasized the absence of safety concerns raised by the ...
Analysis-Trump’s vision for a twin-engine F-55 fighter jet faces reality check
WASHINGTON (Reuters) -U.S. President Donald Trump’s vision of a new, twin-engine version of Lockheed Martin (NYSE: LMT )’s ...
TuHURA Biosciences stock rises following FDA hold lift
The clinical hold’s removal has been positively received by the market as it signals a step forward for TuHURA’s IFx-2.0, which is being developed as an adjunctive therapy in combination with ...
Elevation Oncology stock soars on Concentra merger agreement
Shares of Elevation Oncology Inc (NASDAQ: ELEV) surged 21.2% following the announcement of a definitive merger agreement with Concentra Biosciences, LLC. Under th ...
IonQ stock rises following Oxford Ionics acquisition deal
Dr. Chris Ballance and Dr. Tom Harty, founders of Oxford Ionics, are set to continue their work with IonQ post-acquisition, contributing to quantum technology development in the UK. The combined ...
Axsome shares fall after FDA issues Refusal to File letter
Investing.com -- Shares of Axsome Therapeutics Inc (NASDAQ: AXSM) fell 1.2% following the U.S. Food and Drug Administration’s (FDA) Refusal to File (RTF) letter regarding the company’s New Drug ...
Petrobras: BofA downgrades shares on challenging macro and regulatory risk
The changes in recommendation and target price “reflect a more challenging macro outlook and rising regulatory risks.” In BofA’s view, this scenario implies an increase in the WACC (Weighted Average ...